Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (59017833 74a7 4af8 B04d 6128c57b46be 01)

FDA Label Image

Image (59017833 74a7 4af8 B04d 6128c57b46be 02)

FDA Label Image

30 Tablets (59017833 74a7 4af8 B04d 6128c57b46be 03)

30 Tablets (59017833 74a7 4af8 B04d 6128c57b46be 03)
This is a prescription-only medication with the NDC number 69097-209-02. The medication contains Enictatino 0mg, Emtricitabine 520 pciag, and Tenofovir Disoproxil Fumarate. It is available in tablet form with a strength of 200 mg/300 mg. The manufacturer of the medication is Cipla USA, Inc. The medication comes in a package of 96 tablets and must be dispensed by a pharmacist. Batch overprinting information is provided in a designated area.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.